Chondromyxoid Fibroma is a rare, benign bone tumor that predominantly affects the metaphysis (portion near the growth plate) of long bones, most commonly occurring in the lower extremities. It typically presents in individuals aged 10 to 30 years and is more common in males. Chondromyxoid fibroma is characterized by the presence of chondroid (cartilage-like) and myxoid (mucous-like) tissue. Clinical manifestations include localized pain, swelling, and limited joint mobility. Radiographically, chondromyxoid fibromas often appear as well-defined, eccentric lesions with a characteristic bubbly or honeycomb pattern on imaging studies. Histologically, the tumor consists of chondroblasts, myxoid matrix, and islands of cartilage. Treatment typically involves surgical removal with curettage and, in some cases, bone grafting. Chondromyxoid fibromas are generally considered benign, but they can be locally aggressive and have the potential for recurrence. Comprehensive understanding of chondromyxoid fibromas is crucial in orthopaedics to facilitate accurate diagnosis and appropriate management, ensuring optimal outcomes for individuals affected by this rare bone tumor. Regular monitoring and follow-up are essential to detect any signs of recurrence or complications.
Title : A data driven approach to prehabilitation and rehabilitation for hip and knee replacement patients
Diana Hodgins, Dynamic Metrics Ltd, United Kingdom
Title : Selective denervation for persistent knee pain after total knee arthroplasty: Long-term outcomes
Shaomin Shi, Medical College of Wisconsin, United States
Title : Stem cell treatment is effective and safe for arthritis of the knee and shoulder and for back and neck pain
Chadwick C Prodromos, Rush University, United States
Title : The effect of OTC N-acetyl-cysteine on cobaltemia and cobalturia from cobalt-chromium orthopedic implants
Stephen S Tower, University of Alaska Anchorage, United States
Title : The etiological diagnosis of torticollis
Ali Al Kaissi, Ilizarov Institute, Austria
Title : Acute Traumatic Spinal Cord Injuries(TSCI) – Is the current standard of care evidence based?
W S El Masri, Keele University, United Kingdom